Fig 1: AHR transcriptionally inhibits chemokine CCL2 expression. A The AML12 cells were treated with LPS (500 ng/mL) and ITE (10 nM, or 100) for 24 h. qRT-PCR shows the levels of Ccl2, Ccnd1, Casp1, Casp3, P53 and P21 in DMSO, LPS, LPS + ITE (10 nM), and LPS + ITE (100 nM). B The AML12 cells were treated with LPS (500 nM) and ITE (100 nM) for 24 h with or without CH223191 (10 µM). qRT-PCR shows the levels of Ccl2, Ccnd1, Casp1, Casp3, P53 and P21 in DMSO, LPS, LPS + ITE, and LPS + ITE + CH223191. C The AML12 cells were treated with LPS (500 nM) and Pcmv-Myc-Ahr (1 µg/mL) for 24 h with or without CH223191. qRT-PCR shows the levels of Ccl2, Ccnd1, Casp1, Casp3, P53 and P21 in DMSO, LPS, LPS+Pcmv-Myc-Ahr, and LPS + Pcmv-Myc-Ahr + CH223191. D The possible binding sites of AHR in the promoter regions of Cyp1a1 and Ccl2 were predicted by JASPAR software. E-F The AML12 cells were treated with ITE (10 nM, or 100) for 12 h. qRT-PCR shows the levels of Cyp1a1 and Ccl2 (E). ChIP assays were performed with the Cyp1a1 and Ccl2 promoters in AML12 cells (F). n = 3 per group. The data are presented as the mean ± SEM values. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001
Fig 2: Proposed working model of AHR signaling in cholestatic liver injury (CLI). Cholestasis is associated with gut microbiota dysbiosis, including a reduced abundance of tryptophan-metabolizing bacteria and an increased abundance of LPS-producing bacteria (e.g., Escherichia-Shigella). These alterations are accompanied by disrupted tryptophan metabolism and enhanced translocation of microbial products such as LPS to the liver, which are associated with impaired AHR activation and amplified hepatic inflammatory responses, including increased chemokine expression (e.g., CCL2) and recruitment of inflammatory cells. Pharmacological activation of AHR by tryptophan-derived metabolites (such as ITE) or AAV-mediated AHR overexpression attenuates inflammatory responses and liver injury, at least in part through suppression of chemokine expression. Hepatocyte-intrinsic AHR signaling is depicted as one contributing node within a broader multicellular inflammatory network rather than a dominant determinant of disease severity. This schematic represents a proposed working model based on the present findings
Fig 3: Liver AHR and tryptophan metabolites were abnormally expressed in 0.1% DDC-diet mouse model. A-B Hepatic AHR protein levels in CON and DDC groups by Western blotting, and content quantification by Image J. C PCA, (D-E) OPLS-DA between CON and DDC groups. F Volcano plot of differential metabolites between CON and DDC groups calculated based on VIP > 1, Foldchange ≥ 1.2. G Cluster heat map of the top 100 differential metabolites. H KEGG enrichment analysis of differential metabolites. I Heat map of specific metabolites in the tryptophan metabolic pathway. **, P < 0.01
Supplier Page from Sino Biological, Inc. for Mouse AHR Gene ORF cDNA clone expression plasmid, C-Myc tag